Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$87.41 USD
-0.45 (-0.51%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $87.88 +0.47 (0.54%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
Edwards Lifesciences Corporation [EW]
Reports for Purchase
Showing records 421 - 440 ( 454 total )
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Cohort B a Success; WE WERE WRONG..
Provider: RODMAN & RENSHAW, CO.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Cohort B Data Should Solidify Use in Non-Surgical Patients but Complication Rate Adds Incremental Risk to Cohort A.
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Key Takeaways from Transcatheter Valves Panel Discussion at the R&R Global Healthcare
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Cohort B Data is Likely to be Positive but Risks are Real
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
STRONG SHOWING IN Q2 FOR TRANSCATHETER VALVES; EXPECTATIONS REMAIN HIGH
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Strong THV Sales; US Sapien Data Expected in September
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Edwards Lifesciences Corporation
Industry: Medical - Products
ADJUSTING NUMBERS FOR STOCK SPLIT; RAISING SPLIT-ADJUSTED PT TO $30.
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S